250+ investors that invest in your industry and stage
Transportation
Gaming
Community
Proptech
FinTech
Biotech
Climate
Marketplace
Artificial intelligence
Energy
Hardware
Media (entertainment)
EdTech
Consumer
Health Care
Impact
Enterprise
Agriculture (agtech)
Sustainability
Venture Capital
Restaurants
Fashion
Real Estate
Retail
Infrastructure
Mobile Apps
Beauty
LGBT
Web3
Publishing
Clean Energy
Sporting Goods
Oil and Gas
B2B
Education
Organic Food
Big Data
Renewable Energy
Food and Beverage
Cryptocurrency
Finance
Video Games
Financial Services
Payments
Photography
Celebrity
Art
Medical
Digital Media
Music
Internet
Social Media
Manufacturing
Facebook
Franchise
Blockchain
Legal
Android
Social Impact
Mobile
Google
Construction
Sports
Local
eSports
Enterprise Software
Email
Wellness
Social Network
Hospitality
Travel
Fitness
Mobile Advertising
Cannabis
Recruiting
Platforms
Biotechnology
Medical Device
Wine And Spirits
Automotive
Crowdfunding
Social
CleanTech
InsurTech
SaaS
Software
Film
Theatre
Life Science
Non Profit
Qatar
New Zealand
United States
South Korea
Germany
Australia
India
United Kingdom
Ireland
Canada
Africa
Asia
LATAM
Europe
Oceania
Middle East
China
South Africa
Singapore
Brazil
Japan
Indonesia
Sri Lanka
Vietnam
Spain
Saudi Arabia
Argentina
Armenia
Austria
Bangladesh
Bahrain
Belarus
Bulgaria
Belgium
Bermuda
Chile
Cameroon
Switzerland
Colombia
Belize
Costa Rica
Denmark
Ecuador
Algeria
Czech Republic
Georgia
Estonia
Egypt
Ghana
Hong Kong
Ethiopia
Gibraltar
Faroe Islands
Greece
Finland
Croatia
France
Hungary
Barbados
Kuwait
Italy
Jersey
Israel
Lebanon
Cambodia
Kenya
Cayman Islands
Jordan
Lithuania
Liberia
Liechtenstein
Myanmar
Kazakhstan
Mali
Morocco
Norway
Malaysia
Mexico
Panama
Malta
Mauritius
Peru
Philippines
Nicaragua
Pakistan
Poland
Russian Federation
Romania
Sweden
Rwanda
Serbia
Seychelles
Turkey
Togo
Puerto Rico
Slovenia
Sierra Leone
San Marino
Senegal
Tunisia
Tanzania
Tajikistan
El Salvador
Uganda
Zambia
Uzbekistan
Thailand
Taiwan
Ukraine
Uruguay
Zimbabwe
Venezuela
Portugal
Azerbaijan
Bahamas
Guatemala
Iraq
Iceland
Namibia
Nigeria
United Arab Emirates
Honduras
Bolivia
Isle of Man
Luxembourg
Cyprus
Latvia
Oman
Angel investors
VC Funds
All investors
Download Find emails Save list

Top 50 Biotech Startup Investors in Australia in October 2023

A list of 50 angel investors and VC (Venture Capital) funds that invest in Biotech startups based in Australia. We rank investors based on the number of investments they made in Biotech companies from Australia. We update this investor list every month.

Top 50 Biotech Startup Investors in Australia in October 2023

Investor Biotech Australia investments
Uniseed Ventures 21
Brandon Capital Partners 15
Medical Research Commercialisation Fund (MRCF) 11
Stoic VC 7
OneVentures 6
Melbourne Angels 5
Artesian VC 5
Main Sequence Ventures 4
Starfish Ventures 3
Yuuwa Capital 3
Horizons Ventures 3
Clean Energy Finance Corporation 3
Allan Moss 2
Vectr 2
Lowercarbon Capital 2
South Australian Venture Capital Fund 2
BridgeLane Capital 2
Folklore Ventures 2
Grok Ventures 2
Sydney Angels 2
Possible Ventures 2
Global Health Investment Fund (GHIF) 2
Brisbane Angels 2
Negev Capital 1
Hostplus 1
Lionheart Ventures 1
Investible 1
Tenacious Ventures 1
Plymouth Growth 1
Bioplatforms Australia 1
Australian Nuclear Science and Technology Organization 1
Time Ventures 1
Alium Capital 1
HealthCare Ventures 1
Mercia Fund Managers 1
Southern Cross Venture Partners 1
Giant Leap Fund 1
CP Ventures 1
Agronomics 1
Grand Challenges Canada 1
Ellerston Capital 1
Northpond Ventures 1
Playford Capital 1
UniSA Ventures 1
Acre Venture Partners 1
ATP Innovations 1
Right Click Capital 1
HESTA 1
AbbVie Biotech Ventures 1
Alloy Ventures 1

Get 300+ niche investors in 2 minutes.

Find who invests in your industry, stage, and region in our 200k+ database with AI-powered matching.

Find investors — It's Free!

Trusted by 21,000+ founders from:

Y Combinator Techstars Antler Pioneer On Deck
Investor list
Uniseed Ventures
VC Fund · Brisbane, Queensland, Australia · 3 investments in the past 12 months

Uniseed was established in October 2000 as a $20 million joint venture between the University of Melbourne (UM) and the University of Queensland (UQ). This proof of concept fund (Fund-1) operated with significant input and support from the commercialization offices of the two universities (UniQuest and Melbourne Ventures Limited), with staff ofthese organizations making up the majority of the Investment Committee and leading due diligence and management of most investment opportunities. Over 20 investments, typically of $250,000 - $500,000 were made from this fund.A new $40 million venture fund (Fund-2) ran from 2005-15, with the addition of a third leading university, the University of New South Wales, and a major private institutional investor, the Westscheme superannuation fund. The founding universities (UQ & UM) also committed further funds. Australian Super took over Westscheme's essets and commitments in July 2011.With the start of Fund-2, an independent management team was established, consisting of the CEO and three Investment Managers; one at each university catchment. The Investment Committee was restructured, with dedicated committees established for biotechnology or other technologies. The nominal investment limit was increased to $2.5 million to allow participation in follow-on funding rounds so as to preserve Uniseed's equity position.On 1 November 2015, Uniseed started its third and largest fund (Fund-3) with the addition of the University of Sydney and the CSIRO to the Universities of Queensland, Melbourne and NSW. This followed three high profile exits in the preceding 14 months (Fibrotech; Spinifex & Hatchtech). Each of the five partners committed $10 million over 10 years to the new fund (total fund $50 million).Uniseed’s partner research organisations spent nearly $4 billion on research, making up over 40% of the total research spend at 67 research organisations in Australia. Together, these organisations accounted for nearly 500 invention disclosures (34% of total) and 500 new registered IP rights filed (45% of total) over the same period(2013 National Survey of Research Commercialisation). Unlike private venture capital funds, Uniseed is dedicated to the needs of its research partners, and committed to servicing them consistently over the long term, irrespective of the short term conditions in external capital markets. It works in very close partnership with the research partner commercialisation companies and staff, providing a valuable adjunct to the capabilities these companies and staff provide. They in turn provide a best-practice commercialisation service tailored to their respective organisations. These companies are able to leverage to great effect the scale of operation and expertise of the Uniseed network.The fund is run with commercial discipline, ensuring independence and financial rigor in its investment decision-making processes. Success is measured by a balance of return on investment (including the flow of funds for research to further the commercialisation of intellectual property generated within the research partner catchments), the establishment of viable start-up companies, the generation of research income for research partners and the improvement of partner commercialisation processes.

Show more...

Investment focus

  • Biotechnology, Manufacturing, Health Care
  • Series A, Seed, Funding Round
  • Australia, United States, United Kingdom

Portfolio highlights

  • Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
  • Morse Micro — Smarter, farther, better. Meet the latest Wi-Fi, HaLow, 802.11ah. 10X FARTHER>1Km range, 100x area, 1000x volume 10X EFFICIENCYMulti-year on a single
  • Tiny Bright Things — Melbourne-based company Tiny Bright Things was cofounded in 2020 by long-time research collaborators Ray Dagastine and Chris Bolton. We invented Halo microscopy to transform the way researchers and manufacturers look at small or transparent things. This helps manufacturers in areas like agrichemicals and pharmaceuticals (where the size and shape ofpowders are critical) and researchers at every stage of discovery— particularly in nanotechnology (where samples are especially tiny) and life sciences (where samples are often also transparent).
Show more investments...

Brandon Capital Partners
VC Fund · Melbourne, Victoria, Australia · 3 investments in the past 12 months

Brandon Capital invests in the most promising biomedical opportunities that have the potential to improve the lives of patients.

Show more...

Investment focus

  • Biotechnology, Health Care, Medical
  • Series A, Seed, Series B
  • Australia, United States, United Kingdom

Portfolio highlights

  • CatalYm — Catalym develops antibodies against a placental factor which is overexpressed by various tumour types.
  • Entact Bio — Entact Bio is a biotechnology company that is in the preclinical stages of developing medications to improve protein function. It was founded by a team with deep roots in deubiquitinase (DUB) biochemistry, chemical biology, disease biology, and small-molecule drug development. The company's proprietary EncompassTM platform was designed tocreate enhancement-targeting chimeric (ENTACTM) medicines. ENTACs take advantage of DUBs' ability to regulate proteins.
  • NRG Therapeutics — energizing drug discovery in neurodegenerative diseases.
Show more investments...

Medical Research Commercialisation Fund (MRCF)
VC Fund · Melbourne, Victoria, Australia

Medical Research Commercialisation Fund (MRCF) provides dedicated, investment funding to support the commercialisation of early-stage medical research discoveries that originate from its member institutes. The collaborative nature of the MRCF seeks to foster best practice in the commercialisation of medical innovations.

Show more...

Investment focus

  • Biotechnology, Health Care, Medical
  • Series A, Seed, Series B
  • Australia, United States, United Kingdom

Portfolio highlights

  • Glyscend — Glyscend develops a revolutionary approach to treating type 2 diabetes. The company began with the insight that bariatric surgery can lead to the immediate remission of the disease, and has since been engaged in the development of a non-invasive approach which will act on the same mechanism as surgery but fit within the current care pathway. Thecompany's technology is an orally ingestible intestinal coating that prevents the stimulation of duodenal mucosa and inhibits key neurohormonal pathways in the proximal gut. Glyscend is devoted to providing patients with an effective strategy to keep glucose levels under control and eliminate potential side effects like weight gain and hypoglycemia. Meanwhile, the company aims to provide endocrinologists and primary care physicians with the innovative tools they need to treat the disease instead of merely managing it. It was founded in 2014 by co-founders Ashish Nimgaonkar, Michael Parlato, and Pratik Patel.
  • Currus Biologics — Currus Biologics is a biotechnology company that develop CAR-T cell therapies for the treatment of solid tumour cancers.
  • Azura Ophthalmics — Azura Ophthalmics is a clinical-stage company that develops an innovative portfolio of compounds to advance treatments for MGD, the leading cause of DED. By targeting the root cause of MGD, Azura brings the promise of improved health and well-being to millions of people worldwide who suffer from MGD and other ocular surface diseases where treatmentoptions are currently lacking. Azura is underpinned by an experienced management team with an established track record of successfully developing and commercializing novel treatments for ocular surface diseases. The company headquartered in Tel Aviv-Yafo, Israel with operations in Australia and the U.S.
Show more investments...

Stoic VC
VC Fund · Sydney, New South Wales, Australia · 1 investment in the past 12 months

Stoic VC is an early-stage venture fund backing founders at the forefront of University Innovation. We partner with Uniseed to accelerate the commercialisation of university research across the ANZ.

Show more...

Investment focus

  • Biotechnology, Medical, Health Care
  • Seed, Funding Round, Series A
  • Australia, United States, United Kingdom

Portfolio highlights

  • Ena Respiratory — Ena Respiratory is a biotechnology company seeking to transform the treatment and prevention of respiratory infections and the effectiveness of vaccines.Ena Respiratory novel, synthetic Toll-like receptor 2 (TLR2) receptor agonists have been shown to activate the innate immune system in the respiratory tract and prevent viral and bacterialdissemination to the lungs.
  • BioScout — Welcome to BioScout, your partner in revolutionizing the agriculture industry with cutting-edge automated disease detection technology for crop growers and viticulture. Our high-level introduction and detailed insights into our innovative solutions, exceptional collaborations, and dedicated team make it easy to understand WHO we are, WHAT we do, and HOW we do it. Stay updated with valuable resources, customer portal, and regular content via our blog. Contact us today to collaborate and optimize your farm's productivity and sustainability.
  • Lenexa Medical — Lenexa Medical is driving towards better healthcare solutions for patients in hospital and aged-care by preventing pressure injuries and empowering clinicans.
Show more investments...

OneVentures
VC Fund · Sydney, New South Wales, Australia · 4 investments in the past 12 months

OneVentures is one of Australia’s leading venture capital firms, with over $330M in funds under management. But they do more than invest. They take companies to that all important next stage, by actively shaping their future. They apply their years of international experience, operational and executional expertise to accelerate the growth of theirportfolio companies. A global growth focus drives their investment selection with their current portfolio including companies with truly innovative products tackling multi-billion-dollar problems, from needle-free vaccinations to virtual communications to adaptive e-learning.

Show more...

Investment focus

  • Software, Health Care, Information Technology
  • Series A, Debt Financing, Funding Round
  • Australia, United States, Israel

Portfolio highlights

  • Vaxxas — Vaxxas develops and commercializes needle-free vaccine delivery system. Vaxxas was incorporated in 2011 and is based in Brisbane, Australia.
  • BiVACOR — BiVACOR is a privately held company founded in 2008. Their staff includes world-class engineers, medical specialists, and business executives, who are diligently working to advance this ground-breaking technology. Together, they have established a strong collaborative network that extends both nationally and internationally. Their worldheadquarters is located in Houston, Texas, USA, and their international office is in Brisbane, Australia.
  • ImmVirX — ImmVirX is an Australian company founded in 2019 with a mission to improve outcomes for patients with cancer types in which immunotherapy treatments have limited effect.
Show more investments...

Melbourne Angels
VC Fund · Melbourne, Victoria, Australia

Melbourne Angels was formed in Melbourne, Australia in early 2007. Melbourne Angels is the leading group of private investors in Victoria who actively invest in early stage and growth technology companies.The group has a strong and experienced core of members that generate deal flow, are experienced in evaluation of business propositions and actas mentors for the other members and the entrepreneurs. The members vary in age, gender, ethnicity, profession and type of experience. All members have experience of success at being entrepreneurial.This award winning group is consistently one of the most active startup investors in the country.

Show more...

Investment focus

  • Biotechnology, Information Technology, Manufacturing
  • Angel, Seed, Funding Round
  • Australia, United States, New Zealand

Portfolio highlights

  • Tayble — Spend more time enjoying your food and less time waiting.We hate waiting...For anything...And food and drinks are no exception!If your hobbies include:- Waiting in line - Calling out to a waiter - Watching the kettle boil - Calculating your split of the billPLEASE DO NOT DOWNLOAD THIS APP... YOU'LL HATE IT!But if you're likeus...And want your food and drinks ready exactly when you are...Or to leave a restaurant without worrying about your bill...Then step right up, this bad boy's for you!With Tayble, you’ll never have to flag down a waiter... EVER!Simply order from your "Tayble"Or before you even arrive...Leave the rest to us and the 1,000's of minions in the cloud that keep this all running!You’ll be left asking where has this been all my life, guaranteed!*(Definitely not a real guarantee)
  • Insite AI — We create predictability for consumer brands in the unpredictable world of retail. Game-changing technology that attacks consumer brands' hardest problems.
  • Apop Imaging — Apop Imaging develops and commercialises novel imaging, diagnostic and therapeutic tools to improve patient outcomes based on our proprietary calcitonin receptor antibody technology.
Show more investments...

Artesian VC
VC Fund · Melbourne, Victoria, Australia · 13 investments in the past 12 months

Artesian Capital Management is an alternative investments management company, which was spun out of ANZ Banking Group's capital markets business in 2004, with backing from ANZ Private Equity. Artesian's founding partners, purchased ANZ's stake in 2005. The company has subsequently been fully owned by partners and staff. Since 2004,Artesian has managed specialised funds focused on credit arbitrage and relative-value strategies across global financial markets. In 2008, while continuing to manage credit relative value investment strategies from its New York, London and Singapore offices, Artesian began to make principal investments in seed/early-stage ventures from its offices in Sydney, Melbourne and Shanghai. In 2011, Artesian launched the first of its early stage venture capital funds and now manages AUD +255m. Artesian's VC strategy is to partner with best of breed accelerators, incubators, angel groups and university programs. In 2017, Artesian launched its China VC Fund with a USD 50m cornerstone investment industry super fund Hostplus. Artesian will soon launch a Southeast Asia VC Fund.

Show more...

Investment focus

  • Software, Artificial Intelligence, Information Technology
  • Seed, Series A, Pre-Seed
  • Australia, United States, Hong Kong

Portfolio highlights

  • ZoomAgri — ZOOMAGRI provides an assessment of agricultural commodities to all participants of Agri supply chain via AI, computer vision and IoT.
  • Supplynote — End-to-end supply chain management tool to track inventory, orders, payments and suppliers online
  • Navi Medical Technologies — Navi Medical Technologies is a medical device development company.
Show more investments...

Main Sequence Ventures
VC Fund · Sydney, New South Wales, Australia · 15 investments in the past 12 months

We work with inventors who are building something hard from their unique expertise in science. These inventors are building the industries that will thrive for the decades to come. We have a unique working model to accelerate a company's pathway to scale.

Show more...

Investment focus

  • Software, Artificial Intelligence, Information Technology
  • Series A, Seed, Series B
  • Australia, United States, Philippines

Portfolio highlights

  • Endua — Endua is building the next generation of clean energy deep storage to power communities, remote industries and off-grid infrastructure at the flick of a switch - all day and night
  • Jdoodle — JDoodle is an Online Compiler, Editor, IDE for Java, C, C++, PHP, Perl, Python, Ruby and many more. You can run your programs on the fly online, and you can save and share them with others. Quick and Easy way to compile and run programs online.
  • Number 8 bio — Number 8 bio objective is to decarbonize agriculture while feeding the world's rising population. This can be accomplished by harnessing the power of trillions of carbon-hungry bacteria that feed on harmful greenhouse gases and turn them into profitable animal feeds.
Show more investments...

Starfish Ventures
VC Fund · Melbourne, Victoria, Australia

Starfish Ventures is an Australian venture capital firm focused on information technology, life sciences, and clean technology companies.

Show more...

Investment focus

  • Software, Enterprise Software, Information Technology
  • Series A, Series B, Funding Round
  • United States, Australia, Philippines

Portfolio highlights

  • Aktana — Build stronger relationships with HCPs using Aktana's artificial intelligence (AI) platform for life sciences to optimize omnichannel engagement.
  • DesignCrowd — Crowdsourced logo, freelance graphic and web design at DesignCrowd. 1,136,169 freelance designers compete to create amazing designs for your business. Start Today!
  • Marani — Marani Health is developing a prenatal care platform which includes a wearable, textile-based product to measure key vital statistics of women and their developing fetus, for use during pregnancy, labor & delivery. The products utilize Artificial Intelligence to better assess health & wellness during pregnancy, labor & delivery. Maraniis collaborating with key partners including The Mayo Clinic.
Show more investments...

Yuuwa Capital
VC Fund · Perth, Western Australia, Australia

Yuuwa Capital is a $40M early-stage venture capital firm based in Perth, Western Australia. They are actively seeking outstanding investment opportunities where Yuuwa can provide both capital and expertise to help founders, management and early investors to turn good ideas into great companies.

Show more...

Investment focus

  • Biotechnology, Analytics, Health Care
  • Series A, Seed, Series B
  • Australia

Portfolio highlights

  • Nexgen Plants Pty Limited — Healthy plants, healthy people, living planet. Nexgen develop's plants for future generations that will improve the environment and health of future generations.
  • icetana — icetana Motion Intelligence dramatically improves the active monitoring of security surveillance networks, with AI video anomaly detection and video analytics.
  • Agworld Pty Ltd — Agworld Farm Management software allows you to collect data at all levels and enables you to extract maximum value from this data; optimising profitability. The Agworld ecosystem is utilised by growers, agronomists and service providers on farms across the world.
Show more investments...

Horizons Ventures
VC Fund · Hong Kong, Hong Kong Island, Hong Kong · 17 investments in the past 12 months

Investing in the deep science and technology that can propel humanity towards a radically better future.

Show more...

Investment focus

  • Biotechnology, Artificial Intelligence, Software
  • Series A, Series B, Seed
  • United States, United Kingdom, Canada

Portfolio highlights

  • BioLoomics — BioLoomics is a preclinical stage biotechnology company that uses evolution in a microscope to develop drug discovery tools and protein drugs. Our VariVolve platform tests millions of protein designs for a targeted activity in hours, enabling efficient mining of the vast chemical space of protein designs. A strong advantage of our approach is theuse of whole intact cells as test vessels that capture complex drug behavior not attainable in conventional assays.
  • Erthos — erthos is a producer of biodegradable packaging materials intended to replace traditional polystyrene and polypropylene inputs.
  • ZeroAvia — ZeroAvia is producing the world's first practical zero emission aviation powertrain, initially targeting 20-seat airplanes to start replacing dirty jet fuel in regional transport
Show more investments...

Clean Energy Finance Corporation
VC Fund · Sydney, New South Wales, Australia · 9 investments in the past 12 months

The Clean Energy Finance Corporation invests, applying commercial rigour, to increase the flow of finance into the clean energy sector. Their mission is to accelerate Australia's transformation towards a more competitive economy in a carbon constrained world, by acting as a catalyst to increase investment in emissions reduction. They do thisthrough an investment strategy focused on cleaner power solutions, including large and small-scale solar, wind and bioenergy; and a better built environment, with investments to drive more energy efficient property, vehicles, infrastructure and industry. The CEFC also invests with co-financiers to develop new sources of capital for the clean energy sector, including climate bonds, equity funds, aggregation facilities and other financial solutions. The CEFC operates under the Clean Energy Finance Corporation Act 2012.

Show more...

Investment focus

  • Energy, Solar, Renewable Energy
  • Series B, Series A, Seed
  • Australia, United States

Portfolio highlights

  • Infradebt — Infradebt t is a specialist fund manager providing clients with direct access to infrastructure private debt markets.
  • Gunn Agri Partners — Gunn Agri Partners is an agricultural investment company that offers advice and services for acquisitions, asset, farm, and fund management.
  • HydGene Renewables — Our mission is to accelerate adoption of low carbon technology by providing an alternative green hydrogen solution.
Show more investments...

Allan Moss
Angel · Sydney, New South Wales, Australia

Allan Moss acts an adviser to Anchorage’s Investment Committee. Currently Principal of Allan Moss Investments, a private investment company, Allan retired from the role of Managing Director and Chief Executive Officer of Macquarie Group in May 2008. He was with Macquarie Group for 31 years and served as CEO from 1993 to his retirement in2008. He was also a non- executive director of CSR Ltd from 1996 to 2001.Allan graduated from Sydney University in Arts with a major in Economics and in Laws with Honours. He is also a graduate of Harvard University with a Masters Degree in Business Administration with High Distinction. Allan has received numerous industry awards and recognitions. He was twice named by Barron’s Magazine as one of the 30 most respected CEOs in the world (2006, 2007). He was appointed an Officer of the Order of Australia in 2005.

Show more...

Investment focus

  • Health Care, Medical Device, Biotechnology
  • Funding Round, Series A, Seed
  • Australia, United States, The Netherlands

Portfolio highlights

  • Skykraft — Skykraft is an Australian space services firm that specializes in smallsat constellation design, production, and operation.
  • Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
  • Invert Robotics — Invert Robotics develops robotic NDT inspection technologies for the maintenance of industrial equipment in the food and beverage, pharmaceutical, and oil and gas industries. Invert Robotics highly skilled team of engineers have developed a world leading modular inspection platform suitable for use across a range of industries and applications.
Show more investments...

Vectr
VC Fund · Sheung Wan, Hong Kong Island, Hong Kong · 6 investments in the past 12 months

Vectr is a venture firm based in Hong Kong. They combine investment, creation and growth to deliver game-changing impact to teams ready to tackle global issues, transform industries and improve the lives of millions.That combines capital, creation and partnership to deliver game-changing impact. We strive to be the ideal partner for founders thatare building transformation products and looking to expand their businesses into asia.

Show more...

Investment focus

  • FinTech, Artificial Intelligence, Financial Services
  • Seed, Series A, Pre-Seed
  • United States, Hong Kong, Singapore

Portfolio highlights

  • Percent — Unlock private credit investments with Percent. Access alternative investments on the platform powering the future of private markets.
  • Micro Connect — Micro Connect provides market infrastructure, fintech, and platform development.
  • MasterExchange — Trading platform for music rights leveraging emerging technology to create friction free and compliant investment opportunities to everyone.
Show more investments...

Lowercarbon Capital
VC Fund · New York, New York, United States · 32 investments in the past 12 months

Lowercarbon Capital backs kickass companies slashing CO2 emissions, sucking carbon out of the sky, and buying us time to unf**k the planet.

Show more...

Investment focus

  • Biotechnology, Renewable Energy, Energy
  • Seed, Series A, Funding Round
  • United States, United Kingdom, France

Portfolio highlights

  • Dioxycle — Dioxycle is develop electrolyser solutions for carbon dioxide emissions.
  • Isometric — Isometric is a carbon removal registry and science platform
  • Arc Boats — Arc manufactures and sells high-performance electric boats for watersports.
Show more investments...

South Australian Venture Capital Fund
VC Fund · Adelaide, South Australia, Australia · 1 investment in the past 12 months

South Australian Venture Capital Fund - helping build dynamic and innovative South Australian startups / scaleups and accelerate their growth to a national and global scale.

Show more...

Investment focus

  • Health Care, Biotechnology, SaaS
  • Funding Round, Series A, Series B
  • Australia

Portfolio highlights

  • Lumary — Simplify Your Care Management Optimise Your Organisation Create Better Wellbeing
  • BiomeBank — BiomeBank is a clinical stage biotechnology company with a mission to treat our microbiome and prevent disease by restoring gut microbial ecology.
  • Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
Show more investments...

BridgeLane Capital
VC Fund · Sydney, New South Wales, Australia

The BridgeLane Group is a privately-owned asset management firm specialising in the agricultural, real estate and innovation sectors. A significant global player in agriculture with a multi-decade record in large scale farming, the Group has a proud history in residential property development, comme

Show more...

Investment focus

  • Software, Financial Services, Health Care
  • Seed, Series B, Funding Round
  • Australia, Germany

Portfolio highlights

  • Agerris — Agerris is a field robotics and AI start-up for the agriculture industry, based on technology created at the Australian Centre for Field Robotics, the University of Sydney, where they have been developing air and ground robotic solutions for the agriculture industry since 2005.
  • Sprout Stack
  • Evrima Technologies — Our clinical trial recruitment and management services put participants first. Trusted, timely clinical trial results are a good thing - for everybody.
Show more investments...

Folklore Ventures
VC Fund · Sydney, New South Wales, Australia · 1 investment in the past 12 months

Folklore is a team of investors, founders, and builders committed to supporting Australian and New Zealand tech founders. We are a first cheque to forever investment firm, and we believe in the power of founder vision and the potential of teams, right from the start.

Show more...

Investment focus

  • Software, Apps, Information Technology
  • Seed, Series A, Funding Round
  • Australia, New Zealand, United States

Portfolio highlights

  • Swoop Aero — Transforming how the world moves by making access to the skies seamless.
  • HealthMatch — HealthMatch is a medical technology company that applies machine learning and artificial intelligence to clinical data to save lives.We aim to dramatically accelerate patient recruitment to clinical trials, and progress life-saving cures onto the market faster than existing practices allow.For clinicians and patients, there is a real struggleto identify and find appropriate trials, particularly where the criteria relating to each trial is inconsistently articulated. HealthMatch encodes qualifying questions relating to each patients condition. The platform matches responses to its trial dataset, and confirms only the correct-match trials for that patient — thereby streamlining the identification of suitable trials and facilitating a patient’s application to those trials.With Ai and software at the core, HealthMatch delivers a radically simple product to match patients with drug trials, backed by an execution approach to data that is deceptively complex to achieve and replicate. In doing so, HealthMatch is dramatically changing an industry that has essentially not moved beyond telephones and excel spreadsheets.
  • SimConverse — SimConverse is a simulation platform that uses generative AI to play the role of any patient, colleague or casualty.
Show more investments...

Grok Ventures
VC Fund · Surry Hills, New South Wales, Australia · 6 investments in the past 12 months

Grok Ventures is a private investment company. They back world-class teams solving big problems to shape a better future. They invest in fast growing technology-enabled businesses.

Show more...

Investment focus

  • Renewable Energy, Software, Internet of Things
  • Series A, Series B, Seed
  • Australia, United States, Hong Kong

Portfolio highlights

  • Lydian — Lydian aims to accelerate the decarbonization of the chemical industry by electrifying the chemical production process. Founded in 2021 by Branko Zugic, Lydian is headquartered in
  • Loam Bio — Loam Bio is developing tech that allows for crops to be inoculated with symbiotic micro-organisms.
  • Fleet Space Technologies — Fleet is an agile, next generation connectivity company. Our mission is to Connect Everything using cutting-edge communications and space technologies to maximise the resource efficiency of human civilisation and enable the next industrial revolution with our free, ubiquitous connectivity platform.
Show more investments...

Sydney Angels
VC Fund · Sydney, New South Wales, Australia

Sydney Angels is a not-for-profit angel investment membership organisation. Since our establishment in 2008, they have stayed true to our mission of supporting the early-stage ecosystem by running processes and events that connect our investing members with promising early-stage companiesThey believe that encouraging smart investment in startupcompanies will benefit both our members’ portfolios and Australia’s emergent innovation economy.They see this as the ultimate win-win situation. Sydney Angels is led by an elected committee of ten volunteers who meet weekly. It is supported by an operations manager and alliance partners.

Show more...

Investment focus

  • Software, SaaS, Apps
  • Seed, Funding Round, Angel
  • Australia, United States

Portfolio highlights

  • Kapiche — Instant insights. No set up or coding. The Kapiche feedback analytics platform helps you ingest and analyze mountains of customer feedback in minutes.
  • Remi AI — A.I-Powered Demand Forecasting, Supply Chain AI, & Price Optimisation | Remi AI
  • Trendspek — Trendspek is the drone data solution asset managers use to make empowered decisions and ensure absolute asset knowledge. Conduct complete visual inspections from any web browser. Extract detailed insights without a site visit. Use powerful tools to analyse the structure and build a complete picture of asset condition. Enhance predictive maintenanceby closely monitoring trends. View different models side by side to observe important differences. Refine your understanding of an ever-changing asset.
Show more investments...

Possible Ventures
VC Fund · Munich, Bayern, Germany · 26 investments in the past 12 months

Possible Ventures backs ambitious teams building frontier technology to positively impact society. We invest globally in the early stages, actively supporting founders via our collective of global entrepreneurs.

Show more...

Investment focus

  • Software, Information Technology, Biotechnology
  • Seed, Pre-Seed, Series A
  • Germany, Australia, United States

Portfolio highlights

  • Automata — Automata is a deep-tech company that creates products that empower people to automate physical work. The company's product, Eva, is a lightweight and affordable robot arm built for professionals in a production line, in a lab, a home workshop or even in a classroom. People don't need to be technical experts to communicate with robots. Theweb-based software platform can be programmed by anyone, anywhere, any time, from any device, making it easy to reconfigure for a wide range of different tasks.Automata was founded on 2015 and is headquartered in London, England.
  • Eden Brew — Eden Brew is a ground-breaking new way to enjoy dairy products sustainably and nutritiously.
  • Pow.bio — Pow.bio provides fermentation services for synthetic biology.
Show more investments...

Global Health Investment Fund (GHIF)
VC Fund · New York, New York, United States

The Global Health Investment Fund (GHIF) is a $108 million social impact investment fund designed to provide financing to advance the development of drugs, vaccines, diagnostics and other interventions against diseases that disproportionately burden low- and middle-income countries. GHIF supports late-stage innovations for public health challengessuch as malaria, pre-eclampsia, cholera, HIV and river blindness, with an emphasis on infectious diseases and maternal/infant health issues that cause significant morbidity and mortality in resource-limited settings. GHIF may also make investments that improve or expand access to existing products—such as developing pediatric formulations of approved therapeutics or improving the stability of widely-used global health vaccines.As an investment fund with a limited time-horizon, GHIF seeks opportunities that have a high probability of successful commercialization within two or three years. Products with “dual market” potential are of greatest interest; i.e., those that will have a clear impact on public health in developing countries but also have value in high-income countries. High-volume / low-margin products, such as essential vaccines, are also of significant interest.GHIF employs a range of investment structures including mezzanine debt, convertible debt, preferred equity and project financing with an average investment target of approximately $10 million per project. Each GHIF project must advance the Fund’s social impact objectives and demonstrate the ability to achieve commercial success.

Show more...

Investment focus

  • Health Care, Biotechnology, Medical Device
  • Series B, Series C, Funding Round
  • United States, India, Austria

Portfolio highlights

  • Monod Bio — Monod Bio l Simple. Powerful. Biosensors for Medicine & Biotech.
  • CXL Ophthalmics — CXLO is developing a minimally invasive treatment for an ectatic corneal disease that can bring early intervention to millions of patients globally.
  • Endpoint Health — Endpoint Health is a precision-first therapeutics company. By rewriting the molecule-first drug development model, we aim to deliver precision therapies that have the potential to improve outcomes for patients with immune-driven illnesses.
Show more investments...

Brisbane Angels
VC Fund · Brisbane, Queensland, Australia · 1 investment in the past 12 months

Formed in late 2006, the Brisbane Angels Pty Ltd is a large group of private investors who actively invest in early stage technology companies, usually in South East Queensland, Australia. The members are typically active or semi-retired former senior business executives, who apart from financial input can provide much needed value adding toinvestee companies through hands-on management experience and high level business networks.

Show more...

Investment focus

  • Software, Information Technology, Artificial Intelligence
  • Seed, Angel, Funding Round
  • Australia, United States, New Zealand

Portfolio highlights

  • Tribu — Here at tribu we aim to make running an MSP stress-free and simple. Remove complexity and repetitive shackles to give you the freedom in business so that you can have freedom in life.
  • Avasa — Avasa is a medical device company. It helps to improve surgical procedures by developing novel implantable devices.
  • One Key Access — One Key Access is an interface to the world of couriers to enable 24/7 frictionless deliveries.
Show more investments...

Negev Capital
VC Fund · Grand Cayman, Midland, Cayman Islands · 1 investment in the past 12 months

Psychedelic Medical Intervention Investment Fund

Show more...

Investment focus

  • Biotechnology, Medical, Health Care
  • Seed, Series A, Series B
  • United States, Canada, Australia

Portfolio highlights

  • Psylo — Psylo is an Australia-based psychedelic biotech business focusing on Psychedelic-inspired medicine to treat mental illness.
  • Mindstate Design Labs — A psychedelic drug development company designing altered states of consciousness for mental health therapeutics.
  • Delix Therapeutics — Rewiring the brain to heal the mind
Show more investments...

Hostplus
VC Fund · Melbourne, Victoria, Australia · 10 investments in the past 12 months

Join our leading Australian superannuation fund, committed to putting our members first, with a low admin fee and strong returns. Become a member today!

Show more...

Investment focus

  • Science/Engineering, Software, Sustainability
  • Series B, Series C, Series A
  • Australia, United States, United Kingdom

Portfolio highlights

  • Diffblue — Diffblue helps accelerate your shift left by automatically writing suites of unit regression tests so you can catch errors faster and earlier in your pipeline
  • Vow — Vow is crafting a new category of food
  • Oxbotica — Autonomous Vehicle Software - Any Vehicle, Any Place, Any Time
Show more investments...

Lionheart Ventures
VC Fund · San Francisco, California, United States · 2 investments in the past 12 months

Lionheart Ventures is a global, seed-stage venture capital firm investing in companies that make humanity more resilient. Our focus areas are climate protection, mental health and financial inclusion.

Show more...

Investment focus

  • Information Technology, Health Care, Environmental Engineering
  • Seed, Series A, Funding Round
  • United States, United Kingdom, Singapore

Portfolio highlights

  • Psylo — Psylo is an Australia-based psychedelic biotech business focusing on Psychedelic-inspired medicine to treat mental illness.
  • Trek Health — Trek Health builds foundational software that empowers mental health providers to start working with insurance networks. The company's contact modes are by mail, phone, and physical address.
  • Clerkenwell Health — Clerkenwell Health addresses the growing unmet demand for effective mental health treatments.
Show more investments...

Investible
VC Fund · Sydney, New South Wales, Australia · 20 investments in the past 12 months

Investible is an early-stage venture capital firm backing the visionaries advancing humanity through technology in Australia, New Zealand, Southeast Asia and globally.

Show more...

Investment focus

  • Software, E-Commerce, Information Technology
  • Seed, Series A, Pre-Seed
  • Australia, United States, Singapore

Portfolio highlights

  • Sherlok — Automated client retention for mortgage brokers, helping them grow their loan book by proactively keeping their existing clients happy and with them forever.
  • BintanGO — Creator Marketing Platform terbaik di Indonesia, lebih dari 40.000 Kreator dan 100 Brand sudah bergabung. Buat campaignmu jadi fleksibel, terlacak dan terukur.
  • Inspace XR — Inspire and engage prospective tenants, buyers, and your team with interactive virtual replicas of your assets, with 360 virtual tours, analytics & more.
Show more investments...

Tenacious Ventures
VC Fund · Melbourne, Victoria, Australia · 4 investments in the past 12 months

Tenacious Ventures - Australia's first and only dedicated agrifood tech VC firm.

Show more...

Investment focus

  • Agriculture, AgTech, Software
  • Seed, Pre-Seed, Series A
  • Australia, United States

Portfolio highlights

  • Azaneo — Azaneo develops lightning-fast electric weeding technology. Using only electrons - herbicide free.
  • Earthodic — Earthodic is an Australian materials science company creating functional biobased coatings. Paperbarc by Earthodic is a biobased water-resistant coating for pulped or paper products. It has better water-resistance than wax coatings, more sustainable and circular than plastic coatings. Repulpable. Re
  • SwarmFarm Robotics — Global crop protection specialists ADAMA and Australian ag-tech company.
Show more investments...

Plymouth Growth
VC Fund · Ann Arbor, Michigan, United States · 2 investments in the past 12 months

Growth Capital for Leading Midwest Tech Companies

Show more...

Investment focus

  • Software, Information Technology, Enterprise Software
  • Series A, Funding Round, Series B
  • United States, Canada, Australia

Portfolio highlights

  • CloseSimple — CloseSimple is a real estate based software firm making conversation around buying or selling a house easier through Text Message & Email.
  • Deck Commerce — Deck Commerce Order Management System (OMS) simplifies complex order processes to empower retailers to curate the best customer experience.
  • Forj — Host your association's conferences, trade shows, or events on our highly customizable and interactive virtual event platform, backed by our customer success team.
Show more investments...

Bioplatforms Australia
VC Fund · Port Macquarie, New South Wales, Australia · 1 investment in the past 12 months

Bioplatforms Australia is a non-profit entity that supports life science research in genomic, proteomics, metabolomics, and bioinformatics.

Show more...

Investment focus

  • AgTech, Farming, Agriculture
  • Pre-Seed
  • Australia

Portfolio highlights

  • Number 8 bio — Number 8 bio objective is to decarbonize agriculture while feeding the world's rising population. This can be accomplished by harnessing the power of trillions of carbon-hungry bacteria that feed on harmful greenhouse gases and turn them into profitable animal feeds.
Show more investments...

Australian Nuclear Science and Technology Organization
VC Fund · Clayton, Victoria, Australia

Australian Nuclear Science and Technology Organisation is one of Australia's most important research infrastructures. Thousands of scientists in industry and academia gain access to state-of-the-art instruments every year. ANSTO operates much of Australia's landmark infrastructure, including OPAL, one of the world's most advancednuclear reactors; the Australian Synchrotron; the National Imaging Facility Research Cyclotron; and the Centre for Accelerator Science.

Show more...

Investment focus

  • Health Care, Biotechnology, Pharmaceutical
  • Funding Round
  • Australia

Portfolio highlights

  • Clarity Pharmaceuticals — Clarity is a clinical stage company developing products to address the growing need for the use of radiopharmaceuticals in oncology.
Show more investments...

Time Ventures
VC Fund · 3 investments in the past 12 months

Time Ventures is an investment fund for Marc Benioff.

Show more...

Investment focus

  • Software, Information Technology, Artificial Intelligence
  • Series A, Series B, Seed
  • United States, Canada, Germany

Portfolio highlights

  • SandboxAQ — SandboxAQ is an enterprise SaaS company combining AI + Quantum tech to solve hard problems impacting society.
  • Dryad Networks — Overview of Dryad, providing ultra-early fire detection as well as forest growth and health monitoring.
  • ArteraAI — Discover the power of Personalized Precision Medicine & AI Cancer Therapy with ArteraAI. Transforming cancer therapy through innovation.
Show more investments...

Alium Capital
VC Fund · Sydney, New South Wales, Australia

Alium Capital are Investment Fund Managers offering an Innovative Investment Fund Focused on Generating Returns & Effectively Managing Risk

Show more...

Investment focus

  • Software, Financial, Science/Engineering
  • Series A, Series B, Seed
  • Australia, United States, Singapore

Portfolio highlights

  • Alex — Alex is 100% digital, built from the ground up by an energetic team of bankers, focused on customer's needs, not ours. Further information regarding Alex’s restricted Banking Authority is available at www.alex.bank/legal
  • Beforepay — Beforepay understands that traditional pay cycles are a form of financial stress. So we set out to find a better way, giving Australians the control and confidence that comes with managing your own money, on your terms.That’s why we created Pay On Demand™ - a service that allows you to access the money you have earned at work, when you choose todo so. After all, it is yours!The app also automatically predicts when your bills are due, shows you how much is OK for you to spend, and automatically creates budgets for you, effortlessly.
  • DesignCrowd — Crowdsourced logo, freelance graphic and web design at DesignCrowd. 1,091,001 freelance designers compete to create amazing designs for your business. Start Today!
Show more investments...

HealthCare Ventures
VC Fund · Cambridge, Massachusetts, United States

HealthCare Ventures is a leading life science venture capital firm investing in pre-clinical or early clinical stage, focused companies with potential to transform patient care.

Show more...

Investment focus

  • Biotechnology, Health Care, Pharmaceutical
  • Series B, Series A, Series C
  • United States, Australia, United Kingdom

Portfolio highlights

  • Colorescience — Know Better Skin with Colorescience. From mineral sunscreen to clinical skincare products, achieve a clear, even complexion and protect your skin from the damaging effects of the sun and environmental aggressors such as pollution. Shop Now!
  • Leap Therapeutics — Leap Therapeutics, Inc., a clinical-stage biopharmaceutical company, is engaged in acquiring and developing novel therapeutics. The company focus is to identify translational-stage molecules in the areas of cell signaling and immuno-oncology.
  • Proteostasis Therapeutics — Proteostasis Therapeutics is discovering and developing novel small molecule therapeutics designed to control the body's protein homeostasis, or Proteostasis Network. The Proteostasis Network maintains the body's natural balance of proteins to protect us from numerous diseases. These novel therapies, or Proteostasis Regulators, aredesigned to treat multiple genetic and degenerative disorders associated with deficiencies of the Proteostasis Network, such as emphysema, type II diabetes, Alzheimer's Disease and Huntington's Disease.
Show more investments...

Mercia Fund Managers
VC Fund · Henley In Arden, Warwickshire, United Kingdom · 7 investments in the past 12 months

Mercia Asset Management providing equity and debt to regional businesses with growth ambition. We are your capital partners from scale-up to exit.

Show more...

Investment focus

  • Software, Health Care, Science/Engineering
  • Seed, Funding Round, Series A
  • United Kingdom, United States, Australia

Portfolio highlights

  • Turbine — Turbine builds a platform to understand the inner mechanisms of cancer, enabling the discovery of novel protein targets, precision biomarkers, and better translation to patients. Turbine uses its proprietary Simulated Cell technology in combination with Artificial Intelligence to build a faster and deeper biological understanding of therapeutictargets or indications, untangling the complexity of cancer.
  • Log my Care — Log My Care is a free electronic care planning and care management system for home care providers. Its platform provides a to-do log, which is shared with care employees to let them know their tasks and gives printable reports about activity performance that enable managers to operate care institutes in a hassle-free way.
  • Role Mapper Technologies — Automate and transform how you design and manage job descriptions across your organisation. Hire, retain and grow an inclusive and diverse workforce with AI powered Intelligent Job Design.
Show more investments...

Southern Cross Venture Partners
VC Fund · North Sydney, New South Wales, Australia · 1 investment in the past 12 months

Southern Cross Venture Partners was launched in 2006 by veteran venture capitalists who have managed and operated companies themselves. Southern Cross Venture Partners assist early stage technology companies that demonstrate the potential for exceptional growth and market leadership build significant businesses. The founding principle of SouthernCross is partnership -- they are passionately committed to doing everything they can to help their portfolio companies succeed. Their team has a strong record of utilizing their start-up and management experience, industry knowledge, network of business/customer relationships, and recruiting skills to assist in building significant shareholder value.Southern Cross is currently investing in companies that fit their investment criteria. They prefer to act as lead or co-lead in the early stages where they have experience that can help build value rapidly. They do not have a minimum investment amount, however, a typical initial investment will be $2 million to $5 million with an ability to invest more money in later rounds.

Show more...

Investment focus

  • Software, Manufacturing, Renewable Energy
  • Funding Round, Series B, Series A
  • United States, Australia, Singapore

Portfolio highlights

  • Sunman — Sunman Energy is a technology company founded by a group of industry veterans delivering the future of Solar. Through the research and development of composite materials, Sunman has successfully commercialized the world’s first glass-free, lightweight and flexible Panel – eArc. Replacing glass completely, eArc brings solar power to markets andapplication scenarios that were previously impossible.
  • Wave Computing — The future of high-tech in online casino is a bright one. For example, RFID technology will help casinos track and identify stolen chips. In addition, these systems can also predict player behavior and betting patterns. The latter are especially useful if a player is caught while he is trying to switch out his cards. These ... Read more
  • Brisbane Materials Technology — Since 2005, we have helped thousands of people get the perfect domain name.
Show more investments...

Giant Leap Fund
VC Fund · Melbourne, Victoria, Australia · 5 investments in the past 12 months

Giant Leap is Australia's first venture capital fund to be 100% dedicated to investing in exceptional, rapidly scalable impact businesses.

Show more...

Investment focus

  • Health Care, Software, Sustainability
  • Seed, Series A, Funding Round
  • Australia, United States, United Kingdom

Portfolio highlights

  • Fortanix — Fortanix is building a new security category with its Runtime Encryption(R) technology using Intel SGX. Just like encryption today protects data at rest and data during motion, Runtime Encryption(R) keeps keys, data, and applications completely protected even when infrastructure has been compromised and even root users are malicious.Fortanix's Self-Defending Key Management Service (SDKMS) is a next-generation cloud native solution for your enterprise encryption needs. It offers key generation, management, distribution, encryption-as-a-service, HSM, KMIP, and tokenization all rolled-in as a single product the highest possible level of security and cloud scale. Available as both FIPS certified appliance and a globally available SaaS (with Equinix's strong SLA), SDKMS offers incredible simple central management, server-side load balancing, central tamper-proof logging, RESTful APIs, and Runtime Encryption(R) plugin to run custom code.Fortanix's Runtime Encryption(R) Platform allows customers to bring any docker container and run them securely inside Intel SGX without any modification. It allows customers to share data with each other without losing control of the data, run analytics on sensitive data, run applications securely in remote cloud, move PII-heavy sensitive data to public cloud, etc. Fortanix's Enclave Development Platform (EDP) allows customers to write Rust code to run natively as SGX enclaves. Supported by mainline Rust compiler, developers find EDP as the easiest and the most secure way of developing new applications.In the short time, Fortanix has developed strategic partnership with Equinix and IBM cloud and counts multiple F50 companies as its customers. Fortanix is a Gartner Cool Vendor and also was runner up in RSA Innovation Sandbox among 500+ security companies where judges called it "holy grail of security". Fortanix has more than ten patents pending for its innovation.
  • Mindset Health — Mindset Health is a digital therapeutics company that helps people manage chronic health issues like irritable bowel syndrome and anxiety with app-based hypnotherapy.
  • More Good Days — More Good Days offers evidence-based pain management programes, education, and health services.
Show more investments...

CP Ventures
VC Fund · Sydney, New South Wales, Australia · 3 investments in the past 12 months

CP Ventures is a VC fund that invests internationally in early stage, highly scalable, breakthrough technology companies driven by the 4IR

Show more...

Investment focus

  • Software, Artificial Intelligence, Machine Learning
  • Seed, Pre-Seed, Series A
  • Australia, United States, India

Portfolio highlights

  • Anility — Embed financial health insights within your application using our world leading API service
  • Ahura AI — Ahura AI, an EdTech startup using artificial intelligence to create personalized learning tools that replicate a 1-to-1 learning experience
  • Ensuredit — ENSUREDIT enables and empowers end customers and Insurance Intermediaries with AI-based product platforms for transformational customer experience.
Show more investments...

Agronomics
VC Fund · Douglas, South Lanarkshire, United Kingdom · 6 investments in the past 12 months

Venture capital investment can raise funds for your small business. Venture Capital Firms in the UK like Agronomics is a biotech venture capital firm which invest into the clean meat sector.

Show more...

Investment focus

  • Biotechnology, Food and Beverage, Food Processing
  • Seed, Series A, Series B
  • United States, Finland, Australia

Portfolio highlights

  • Meatable — Meatable is a food production company that produces real and guilt-free meat. With one cell, they are revolutionizing the meat industry's impact on climate change and animal welfare. At the same time they increase food security, without compromising the culinary experience of eating tasty, real meat. They aim to satisfy the world'sappetite for meat without harming people, animals, and the planet.It was founded in 2018 and is headquartered in Delft, South Holland, The Netherlands.
  • Clean Food Group — Clean Food Group provides sustainable ‘CLEAN’ alternatives to these fats and oils, ranging from liquid oils like soybean to hard fats like palm oil, cocoa butter, and milk fat. Clean Food Group produces sustainable food ingredients that are better for our environment and health without compromising on teste or performance.
  • HydGene Renewables — Our mission is to accelerate adoption of low carbon technology by providing an alternative green hydrogen solution.
Show more investments...

Grand Challenges Canada
VC Fund · Toronto, Ontario, Canada

Grand Challenges Canada is dedicated to supporting Bold Ideas with Big Impact® in global health. They are funded by the Government of Canada and they fund innovators in low- and middle-income countries (LMICs) and Canada. The bold ideas they support integrate science and technology, social and business innovation – they call this IntegratedInnovation®. They focus on bringing successful innovation to scale, catalyzing sustainability and impact. They have a determined focus on results, and on saving and improving lives.Grand Challenges Canada works closely with Canada’s International Development Research Centre (IDRC), the Canadian Institutes of Health Research (CIHR) and Global Affairs Canada to catalyze scale, sustainability and impact. Grand Challenges Canada takes an evidence-based approach to development innovation to save and improve lives in LMICs. They are a platform for development innovation in Maternal, Newborn and Child Health (MNCH) through their Saving Lives at Birth, Saving Brains and MNCH Stars in Global Health programs. They are also focused on helping the poorest and most vulnerable populations, for example those who suffer from mental illness.Since their launch in 2010, Grand Challenges Canada has supported a pipeline of over 700 projects in more than 80 countries. Their investments are producing results: Thousands of lives have been saved and over two hundred and eighty thousand lives have been improved, thus far. By 2030, these innovations have the potential to save hundreds of thousands of lives and improve millions of lives.

Show more...

Investment focus

  • Health Care, Medical Device, Biotechnology
  • Grant, Seed, Debt Financing
  • Canada, United States, Australia

Portfolio highlights

  • OmniVis — OmniVis is a technology company creating handheld devices to rapidly detect dangerous pathogens - saving food and saving lives.
  • Nivi, Inc. — Nivi is the best digital health chatbot built for whatsapp and rooted in behavioral science. Nivi enables users to take charge of their own health and works with private and public agencies to driver better public health outcomes.
  • Sensoreal — Sensoreal Inc. is a diagnostic device and service provider company. The company is developing a variety of biosensors, which can perform one-step immunoassays in low-cost, accurate and quantifiable manners. Sensoreal was founded in 2014, and is headquartered in Montreal, Canada.
Show more investments...

Ellerston Capital
VC Fund · Sydney, New South Wales, Australia · 1 investment in the past 12 months

Ellerston Capital is a specialist investment manager with a distinctive approach to portfolio construction and investment selection.

Show more...

Investment focus

  • Software, Information Technology, E-Commerce
  • Funding Round, Seed, Series A
  • Australia, Hong Kong, United Kingdom

Portfolio highlights

  • Willed — Willed is an Australian online estate planning platform.
  • BiomeBank — BiomeBank is a clinical stage biotechnology company with a mission to treat our microbiome and prevent disease by restoring gut microbial ecology.
  • Internet 2.0 — Military Grade cyber security with core products Cloaking Firewall, Malcore and 5th Column
Show more investments...

Northpond Ventures
VC Fund · Bethesda, Maryland, United States · 21 investments in the past 12 months

Northpond Ventures is a science-driven venture capital firm headquartered in Bethesda, Maryland. Our mission is to build a better tomorrow. Our investments are focused on life sciences, technology, and affiliated industries.

Show more...

Investment focus

  • Science/Engineering, Biotechnology, Health Care
  • Series A, Series B, Series C
  • United States, United Kingdom, Australia

Portfolio highlights

  • Sound Agriculture — Sound Agriculture is creating a more agile and resilient food system with innovative on-demand crop solutions.
  • Vestaron — Are you interested in biological peptides? If so, get in contact with Vestaron today. We will keep you informed about safer crop protection.
  • EnPlusOne Biosciences — EnPlusOne Biosciences provides innovative solutions for emerging RNA therapeutics.
Show more investments...

Playford Capital
VC Fund · Adelaide, South Australia, Australia

Playford Capital is a venture capital arm of South Australian Government Financing Authority specializing in investments in start-ups, early venture, mid venture, late venture stages, and growth capital.

Show more...

Investment focus

  • Health Care, Biotechnology, Medical Device
  • Series A, Series B
  • Australia

Portfolio highlights

  • Signostics — Signostics produces Biotech medical devices. Their flagship product, Signos, allows healthcare professionals to use ultrasound in their clinical practice. It offers ultrasound platform technology that clinicians can place in their pocket or wear around their neck like a stethoscope. Just as handheld devices transformed the business world, it isanticipated the Signos will change the way healthcare professionals practice medicine.Signostics was established in Adelaide, Australia in 2005 and expanded into the U.S. in 2008, dedicated to developing fast and affordable point‐of‐care medical devices. The company launched its first product into the veterinarian market in January 2009 andgained regulatory approvals to enter the human medical device market for the United States, Europe, and Australia in May 2009. Signostics has offices in Palo Alto, California and Adelaide, South Australia.
Show more investments...

UniSA Ventures
VC Fund

UniSA Ventures is the technology commercialisation and investment management company of the University of South Australia (UniSA).

Show more...

Investment focus

  • Software, Health Care, Biotechnology
  • Seed
  • Australia

Portfolio highlights

  • Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
  • Framework — All-in-one productivity tool for teams & individuals.
Show more investments...

Acre Venture Partners
VC Fund · Santa Monica, California, United States · 3 investments in the past 12 months

Driven by a mission to redefine food, Acre invests in companies creating systemic change in the food system to address the growing problems of human and environmental health. Acre makes venture-stage investments in highly disruptive platform business across the food value chain, with a particular focus on the agriculture, food tech and consumerverticals. Taken together, these investments have the ability to form the foundation of an integrated new approach to food system evolution.

Show more...

Investment focus

  • Food/Beverage, Gaming, Science/Engineering
  • Series A, Series B, Series C
  • United States, Brazil, Argentina

Portfolio highlights

  • Planet FWD — Planet FWD is the leading carbon assessment platform for consumer brands.
  • Loam Bio — Loam Bio is developing tech that allows for crops to be inoculated with symbiotic micro-organisms.
  • People Science — People Science offers data collection technology and services for clinical research studies of alternative medicines and wellness interventions.
Show more investments...

ATP Innovations
VC Fund

ATP Innovations accelerates the growth of technology companies that target global markets, by providing advice and guidance from seasoned entrepreneurs, access to investors, customers and domain specialists, and world-class infrastructure tailored to the needs of startup companies. The ATP Innovations Accelerator HUB is home to Startmate, IgnitionLabs and university accelerator programs. ATP Innovations’ portfolio comprises over 65 companies from the software, hardware and life science sectors.

Show more...

Investment focus

  • Health Care, Biotechnology, Pharmaceutical
  • Funding Round
  • Australia

Portfolio highlights

  • Clarity Pharmaceuticals — Clarity is a clinical stage company developing products to address the growing need for the use of radiopharmaceuticals in oncology.
Show more investments...

Right Click Capital
VC Fund · Sydney, New South Wales, Australia · 1 investment in the past 12 months

Right Click Capital - Australian Venture Capital Firm

Show more...

Investment focus

  • Software, IT, Data and Analytics
  • Seed, Funding Round, Series A
  • Australia, Singapore, United States

Portfolio highlights

  • Tribu — Here at tribu we aim to make running an MSP stress-free and simple. Remove complexity and repetitive shackles to give you the freedom in business so that you can have freedom in life.
  • Cydarm — A case management platform that enables cybersecurity operations teams to collaborate, integrate, and respond with ease.
  • Reejig — At Reejig, we believe in zero wasted potential in people and in business – and that starts with harnessing the skills you have within your organisation. Our workforce intelligence platform provides 100% visibility of your people’s skills, potential, passions and experiences, creating a powerful central nervous system for all talent decisions.Powered by the world’s first independently audited Ethical Talent AI engine, Reejig generates the intelligence to instantly fill roles, track retention risks, mobilise talent to opportunities, pivot talent for reskilling and much more. Plus, we give you the power to ‘nudge’ people to new career opportunities, taking your engagement with internal and external talent to the next level. Put simply, we make workforce agility a reality.Reejig is trusted and used by some of the largest and most complex organisations including Woolworths, KPMG, NSW Government, John Holland, MYOB and UTS, and together we are creating a world where everyone can reach their full potential at work. It’s what we call zero-wasted potential in people and in business.
Show more investments...

HESTA
VC Fund · Melbourne, Victoria, Australia

HESTA Super Fund is the Australian industry superannuation fund for people working in health and community services. Become a member today.

Show more...

Investment focus

  • Sensor, Medical, Aerospace
  • Series A, Series B, Series C
  • Australia

Portfolio highlights

  • Baraja — Baraja is a deep technology company that has reinvented LiDAR for self-driving vehicles. Our patented platform, Spectrum-Scan™, takes a fundamentally different approach to LiDAR. Instead of relying on fragile moving parts and oscillating mirrors, we simply refract light through a prism to scan the environment. This patented method allows us todeliver unprecedented range, precision, and reliability in even the most extreme environments.
  • Citadel Group Ltd — Citadel develops and delivers technology and education solutions to state and federal government departments, and the private sector in Australia. The company operates through Technology and Education segments. The Technology segment sells professional and managed services to government agencies and private enterprises. Its services includestrategic advice, program management, acquisition support, and quality assurance services through consulting, contracting, and placement mechanisms; technology and integration services; and software solutions, products, and managed services for digital health, diagnostic laboratories, and clinical applications. The Education segment delivers a range of nationally-accredited business qualifications that enable students to articulate into second year university or to gain practical skills for employment.
  • Gilmour Space Technologies — Gilmour Space is a rocket company in Australia that is developing and launching low-cost small satellite launch vehicles. All orbits, all planets: https://www.gspacetech.com
Show more investments...

AbbVie Biotech Ventures
VC Fund · North Chicago, Illinois, United States · 1 investment in the past 12 months

AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. Togetherwith its wholly-owned subsidiary, Pharmacyclics, AbbVie employs ~29,000 people worldwide and markets medicines in more than 175 countries.

Show more...

Investment focus

  • Biotechnology, Science/Engineering, Health Care
  • Series A, Series B, Series C
  • United States, China, Italy

Portfolio highlights

  • Nitrase Therapeutics — Nitrase Therapeutics is a platform company developing drugs against a newly identified class of enzymes called Nitrases, initially targeting Parkinson’s disease. The therapies that Nitrome is developing will target these enzymes and potentially help slow or halt the progression of diseases such as Parkinson’s. While the initial focus is onParkinson's disease, the company aims to expand its proprietary platform to include other disease indications.
  • Quanta Therapeutics — Quanta is a biotechnology company uncovering novel cancer therapeutic candidates using allosteric modulation to target driver oncogenes. The company was founded in 2018 and is based in San Francisco, CA.
  • AmbAgon Therapeutics — AmbAgon Therapeutics is a developer of cancer molecule therapeutics. The company offers research of a small molecule that augments a tumor-suppressing protein. AmbAgon Therapeutics was founded by Christian Ottmann, Lucas Brunsveld, and Michelle Arkin.
Show more investments...

Alloy Ventures
VC Fund · Palo Alto, California, United States

Alloy Ventures is an early stage venture capital firm that invests in the areas of life sciences, information technology, and cleantech.

Show more...

Investment focus

  • Software, Science/Engineering, Hardware
  • Series C, Series B, Series D
  • United States, Canada, Australia

Portfolio highlights

  • Agari — Agari is the Trusted Email Identity Company™, protecting brands and people from devastating phishing and socially-engineered attacks. Using applied data science and a diverse set of signals, Agari protects the workforce from inbound business email compromise, supply chain fraud, spear phishing, and account takeover-based attacks, reducing businessrisk and restoring trust to the inbox. Agari also prevents spoofing of outbound email from the enterprise to customers, increasing deliverability and preserving brand integrity.
  • AEGEA Medical — Mara, a safe and effective in-office treatment that uses natural water vapor to reduce heavy menstrual bleeding in premenopausal women
  • Restoration Robotics — Restoration Robotics is a privately held medical device company, is dedicated to revolutionizing the field of hair transplantation by developing and commercializing a state-of-the-art image-guided system (ARTAS™ System) that enables follicular unit extraction.
Show more investments...
Investors by industry
Investors by country
Investors in Australia by industry

Close your round

Find who invests in your industry, stage, and region in our 200k+ database with AI-powered matching.

Find investors — It's Free!

Join 21,000+ founders from:

Y Combinator Techstars Antler Pioneer On Deck